778 Participants Needed

POST Facilitation for Post-Traumatic Stress Disorder

(POST-RCT Trial)

Recruiting at 2 trial locations
ES
AM
AM
Overseen ByAlexia M Torke, MD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

We propose to study the effects of Physician Orders for Scope of Treatment (POST) Facilitation in a randomized controlled trial in a population of community dwelling older adults who qualify for POLST facilitation, including those with normal cognition and those with Alzheimer's Disease and Related Disorders.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Home Safety Evaluation, POST Facilitation for PTSD?

The research suggests that psychological interventions, like cognitive processing therapy, are effective for PTSD, with significant symptom reductions reported. Additionally, early interventions targeting the mechanisms of PTSD can be beneficial, as indicated by studies on web-based cognitive-affective remediation.12345

Is POST Facilitation for PTSD safe for humans?

There is a need for more comprehensive monitoring and reporting of adverse events (unintended negative effects) in psychological interventions, including those for PTSD, to ensure safety. Current practices often overlook less severe side effects, which means safety data may be incomplete.678910

How is POST Facilitation treatment different from other PTSD treatments?

POST Facilitation is unique because it focuses on psychophysiological interventions, which address the body's physical responses to stress, unlike traditional therapies that primarily focus on psychological aspects. This approach may include techniques like self-hypnosis and clinical hypnosis, which are not commonly used in standard PTSD treatments.311121314

Research Team

AM

Alexia M Torke, MD

Principal Investigator

Regenstrief Institute, Indiana University

Eligibility Criteria

This trial is for community-dwelling older adults aged 65 or above with certain serious health conditions like metastatic cancer, heart failure, kidney disease, COPD, or advanced Alzheimer's. They must have a high risk of mortality within a year and either be able to make decisions themselves or have a surrogate decision maker. Those already in hospice care or with an existing POST form are excluded.

Inclusion Criteria

I am 65 years old or older.
Patients must be able to pass consent verification
Patients must not have a POST form on file
See 11 more

Exclusion Criteria

Lack of a patient or surrogate decision maker who can participate in POLST facilitation (for non-decisional patients a health care representative (HCR) or designated power of attorney for health care (DPOA-HC) must enroll with them)
Patients who are not community-dwelling
Patients who are already enrolled in hospice
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive POST Facilitation or Home Safety Evaluation

1 visit
1 home visit

Follow-up

Participants are monitored for outcomes such as decision conflict, psychological well-being, and POST form completion

12 months

Outcome Assessment

Assessment of primary and secondary outcomes including discordance between treatment preferences and treatment received

12 months

Treatment Details

Interventions

  • Home Safety Evaluation
  • POST Facilitation
Trial Overview The study is testing the effectiveness of Physician Orders for Scope of Treatment (POST) Facilitation compared to usual care in improving outcomes for older adults. It involves home safety evaluations and discussions about treatment preferences in case of severe illness.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Intervention (POST Facilitation)Experimental Treatment1 Intervention
A nurse will complete a home visit with the patient and their surrogate decision maker or other family (if they've designated one), in which he or she will provide education about the POST form. The POST facilitators will be nurses trained using the Respecting Choices Advanced Steps model.
Group II: Attention Control (Home Safety Evaluation)Experimental Treatment1 Intervention
A nurse will complete a home visit with the patient and their surrogate decision maker or other family member (if they've designated one), in which he or she will provide suggestions on how to improve the safety of the patient's home.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Regenstrief Institute, Inc.

Collaborator

Trials
27
Recruited
98,500+

Indiana University Health

Collaborator

Trials
35
Recruited
18,500+

Eskenazi Health

Collaborator

Trials
14
Recruited
3,700+

Respecting Choices

Collaborator

Trials
2
Recruited
830+

Findings from Research

A systematic review of 66 trials involving 4190 patients with PTSD found that specific psychological interventions, such as cognitive behavioral therapy and exposure therapy, have large effect sizes, indicating they are effective in reducing PTSD symptoms.
No single psychological intervention was found to be consistently superior to others, but adherence to PTSD diagnostic criteria and trial quality were linked to larger effect sizes, suggesting that the effectiveness of these interventions can vary based on how well the trials are conducted.
Integrating fragmented evidence by network meta-analysis: relative effectiveness of psychological interventions for adults with post-traumatic stress disorder.Gerger, H., Munder, T., Gemperli, A., et al.[2014]
The study outlines a design for a web-based cognitive remediation training aimed at enhancing neurocognitive functions that may help prevent the development of PTSD in trauma survivors.
By focusing on early intervention shortly after trauma exposure, the study aims to address the challenges of administering targeted training to improve emotional reactivity and regulation, potentially reducing PTSD symptoms.
Evaluating web-based cognitive-affective remediation in recent trauma survivors: study rationale and protocol.Fine, NB., Achituv, M., Etkin, A., et al.[2020]
A systematic review of 126 randomized controlled trials found that certain factors, like having a comorbid diagnosis of depression and higher baseline PTSD severity, are linked to less effective treatment outcomes for PTSD.
Conversely, factors such as higher education, adherence to treatment homework, and experiencing a more recent trauma were associated with better treatment outcomes, highlighting the need for personalized approaches in PTSD therapy.
A systematic review of factors associated with outcome of psychological treatments for post-traumatic stress disorder.Barawi, KS., Lewis, C., Simon, N., et al.[2022]

References

Integrating fragmented evidence by network meta-analysis: relative effectiveness of psychological interventions for adults with post-traumatic stress disorder. [2014]
Evaluating web-based cognitive-affective remediation in recent trauma survivors: study rationale and protocol. [2020]
Using a Learning Collaborative Model to Disseminate Cognitive Processing Therapy to Community-Based Agencies. [2019]
Metacognitive therapy for PTSD: a preliminary investigation of a new brief treatment. [2018]
A systematic review of factors associated with outcome of psychological treatments for post-traumatic stress disorder. [2022]
Editorial: Primum non nocere - are adverse events accurately reported in studies on psychological interventions for children? [2023]
Occupational well-being in pediatricians-a survey about work-related posttraumatic stress, depression, and anxiety. [2020]
Second Victim Support at the Core of Severe Adverse Event Investigation. [2023]
[Patients and doctors experiences of iatrogenic injury]. [2008]
10.United Statespubmed.ncbi.nlm.nih.gov
The need for expanded monitoring of adverse events in behavioral health clinical trials. [2012]
New insights into secondary prevention in post-traumatic stress disorder. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
An Evidence-Based Review of Early Intervention and Prevention of Posttraumatic Stress Disorder. [2018]
The Frustrated and Helpless Healer: Pathways Approaches to Posttraumatic Stress Disorders. [2018]
Post-traumatic stress disorder. [2018]